Liquidia Corp (LQDA) stock
LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3079% above fair value
$54.43−2.20 (-3.88%)
Close on Nov 20, 2026Market cap $4.87BP/E 39.2Yield –
Liquidia shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Liquidia's shares outstanding was 101M at Jun 30, 2026. For fiscal 2025 it was 86M, up 9.3% from the year before. The highest annual figure on record is 86M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 86M | +9.3% |
| FY2024 | Dec 31, 2024 | 79M | +21.1% |
| FY2023 | Dec 31, 2023 | 65M | +6.6% |
| FY2022 | Dec 31, 2022 | 61M | +22.7% |
| FY2021 | Dec 31, 2021 | 50M | +46.6% |
| FY2020 | Dec 31, 2020 | 34M | +83.4% |
| FY2019 | Dec 31, 2019 | 18M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 101M | +18.5% |
| Q1 FY2026 | Mar 31, 2026 | 101M | +18.7% |
| Q4 FY2025 | Dec 31, 2025 | 87M | +2.9% |
| Q3 FY2025 | Sep 30, 2025 | 86M | +10.2% |
| Q2 FY2025 | Jun 30, 2025 | 86M | +12.0% |
| Q1 FY2025 | Mar 31, 2025 | 85M | +13.0% |
| Q4 FY2024 | Dec 31, 2024 | 85M | +28.9% |
| Q3 FY2024 | Sep 30, 2024 | 78M | +20.8% |
| Q2 FY2024 | Jun 30, 2024 | 76M | +18.0% |
| Q1 FY2024 | Mar 31, 2024 | 75M | +16.6% |
| Q4 FY2023 | Dec 31, 2023 | 66M | +1.7% |
| Q3 FY2023 | Sep 30, 2023 | 65M | +0.6% |
| Q2 FY2023 | Jun 30, 2023 | 65M | +4.2% |
| Q1 FY2023 | Mar 31, 2023 | 65M | +23.2% |
| Q4 FY2022 | Dec 31, 2022 | 65M | +23.7% |
| Q3 FY2022 | Sep 30, 2022 | 64M | +23.8% |
| Q2 FY2022 | Jun 30, 2022 | 62M | +22.3% |
| Q1 FY2022 | Mar 31, 2022 | 52M | +20.8% |
| Q4 FY2021 | Dec 31, 2021 | 52M | +28.0% |
| Q3 FY2021 | Sep 30, 2021 | 52M | +37.9% |
| Q2 FY2021 | Jun 30, 2021 | 51M | +78.5% |
| Q1 FY2021 | Mar 31, 2021 | 43M | +52.8% |
| Q4 FY2020 | Dec 31, 2020 | 41M | – |
| Q3 FY2020 | Sep 30, 2020 | 38M | – |
| Q2 FY2020 | Jun 30, 2020 | 28M | – |
| Q1 FY2020 | Mar 31, 2020 | 28M | – |
See a number that looks wrong?